SAVA Stock: Growing Expectations. Phase 3 Study Ongoing. Rival Biogen Failing. Cassava Sciences Inc.

Now SAVA stock is trending again, and it’s for better reasons this time. The citizen’s petition is behind them, and Cassava is focusing on its second Phase 3 Study to evaluate the effectiveness of its lead drug.---
Cassava Sciences stock SAVA is currently one of the most contentious
publicly trade US stock as of today the 27th of Dec. 2021.
The controversy and allegations of data manipulation goes all the way
back to 2005.
Two academic journals have cleared the company of any manipulation the
latest being the Neuroscience journal and the other the Journal of
Remi Barbier, President & CEO stated recently:
This reinforces my conviction that false and misleading allegations of
scientific misconduct being made against us are simply designed to
enrich those making them.

Simufilam is a new oral drug candidate from Cassava Sciences for the
proposed treatment of mild-to-moderate Alzheimer's disease.
On the 23rd of Dec.2021 Cassava Sciences announced the launch of a new
clinical website, called is intended to provide access, visibility and
information on Cassava Sciences' Phase 3 safety and efficacy studies of
oral simufilam

Over 25 clinical sites across the US are now participating in this Phase
3 efficacy studies of Simufilam in Alzheimer's disease.

Improving the eligibility criteria for participation in its Expanded
Access clinical trial

Broadening of its criteria as it concerns RethinkALZ and RefocusALZ
Clinical Research Studies

Any hint that advanced and severe Alzheimer's disease can be
acommodated in these trials or subsequent ones.

Early approval of the drug Simufilam and if there is hope for treating
Alzheimer's Disease

sava stock news
cassava sciences
sava stock buy or sell
sava stock forecast 2025
sava stocktwits
sava stock reddit
sava stock discussion
Is Sava a buy or sell?
Is Sava overvalued?
Why did Sava stock go down?
Who owns Sava stock?
sava stock catalyst
cassava sciences fda approval
sava stock discussion
sava stock forecast 2025
sava news release
sava ad
sava stock news
cassava sciences
sava clinical trials
Be the first to comment